Loading...
NYSE: BSX
Boston Scientific Corporation
Healthcare · Medical - Devices
●S&P 500 since 1995
Market Cap
$105.77B
52w High
$109.50
52w Low
$67.56
P/E
36.57
Volume
7.64M
Outstanding Shares
1.48B
Company profile
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
CEOMichael F. Mahoney
SectorHealthcare
IndustryMedical - Devices
Employees53,000
IPO dateMay 19, 1992
Valuation
Forward P/E—
EV/EBITDA40.59
Enterprise value$151.53B
Stock splits
Nov 6, 20032:1
Dec 1, 19982:1
Profitability & growth
Revenue growth15.9%
Gross margin69.01%▲12.56%vs FY2024
Operating margin19.78%▲25.73%vs FY2024
ROE11.91%▲39.84%vs FY2024
Analyst consensus
RatingBuy
Target price$108.35▲52.01%
40
Buy
3
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 22, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$0.75
$0.73
Q3FY25
ActualEst.
$0.75
$0.71
Q4FY25
ActualEst.
$0.80
$0.78
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$5.06B
$4.89B
Q3FY25
ActualEst.
$5.07B
$4.97B
Q4FY25
ActualEst.
$5.29B
$5.28B
Q1FY26
Next Est.
—